Analyst Ratings for Impax Laboratories Inc. (IPXL)Updated: 2017-07-27
An average rating of Hold has been given to Impax Laboratories Inc. (NASDAQ:IPXL) by analysts covering the stock. A consensus rating of Hold was previously issued for IPXL last month.
3 analysts declared IPXL a buy, 0 gave an overweight rating, 8 issued a hold rating, 0 gave an underweight rating, and 1 gave a sell rating. Compared to three months ago, there has been an increase of 1 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has decreased by 1.
Several price targets were given for IPXL by the analysts covering the stock. The most optimistic analyst gave a price target of 21, implying potential capital gains of 7.69 percent. The minimum price target given was 12, implying potential capital losses of -38.46 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -12.5 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 1.55 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -8.39 percent.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts made negative revisions. Also over the last month, 3 analysts increased their estimates for the FY earnings, while 0 analysts made negative revisions to their fiscal year's estimates.
In the trailing 52-weeks, IPXL hit 31.85 at the highest peak, while it's lowest trading point was 7.75. The current market price is above the trailing year's low by 151.61 percent, and 38.78 percent lower than its 52-week high. IPXL has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The IPXL value stock report compares IPXL to some of its peers using value stock charts. The stock has a market capitalization of $1.46 billion. IPXL's next earnings release will be on 0000-00-00, which is days away.